To conclude, we have generated a stable mutant zebrafish model of AGS5, which exhibited several clinically relevant phenotypes, including neurological manifestations which have rarely been replicated in other pre-clinical models of AGS, thus reinforcing the usefulness of zebrafish as a pre-clinical species for type I interferonopathy research. This evidence concerns the gene SAMHD1 and Aicardi-Goutieres syndrome.